When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
The rejections are not the obstacle — they are the curriculum. And if you pay attention, they can teach you more about your business than any accelerator program or startup playbook ever will.
If I lost everything tomorrow and had to rebuild to seven figures in 12 months using only AI, I wouldn’t guess — I’d reverse-engineer the people who already did it.
The rejections are not the obstacle — they are the curriculum. And if you pay attention, they can teach you more about your business than any accelerator program or startup playbook ever will.